E-Seq Medical is Decision/Risk Analysis in China that focus on cerebrovascular diseases business. Founded in 2016. They cover business area such as developer, gene sequence product, genetic risk assessment, essential hypertension, cerebrovascular disease, development, susceptible gene testing product, artificial intelligence technology, gene sequence service, patient, their hypertension treatment efficiency.
2016
( 8 years old in 2024 )
Cerebrovascular Diseases
-
3rd Floor, Building C,Innovation Building
Zhongguancun Life Science Park
Beijing
China
Private
developergene sequence productgenetic risk assessmentessential hypertensioncerebrovascular diseasedevelopmentsusceptible gene testing productartificial intelligence technologygene sequence servicepatienttheir hypertension treatment efficiency
* We use standard office opening hours in near E-Seq Medical's location as default value for unknown and outdated data. For more valid info, please verify the info from more trusted sources like GoogleMyBusiness, Yelp, FourSquare or similar services.
E-Seq Medical is Decision/Risk Analysis business from China that founded in 2016 (8 years old in 2024), E-Seq Medical business is focusing on Cerebrovascular Diseases.
E-Seq Medical headquarter office and corporate office address is located in 3rd Floor, Building C,Innovation Building Zhongguancun Life Science Park Beijing China.
E-Seq Medical was founded in China.
In 2024, E-Seq Medical is currently focus on cerebrovascular diseases sector.
Above is snippet of Google Trends for "cerebrovascular diseases" term, if you have problem loading the snippet, please visit here: Google Trend.
Disclaimer: This website is not affiliated with E-Seq Medical, any government agency, does not create this data, vouch for its accuracy, or guarantee that it is the most recent data available. The data displayed is available through open government websites and public online directory. This website expressly disclaims the accuracy, adequacy, or completeness of any data and shall not be liable for any errors, omissions or other defects in, delays or interruptions in such data, or for any actions taken in reliance thereon.
